| Catalog | name | Description | price |
|---|---|---|---|
| R-M-1340 | GPS1573 Peptide | GPS1573 is a newly described potent and dose-dependent peptide antagonist of ACTH-stimulated melanocortin type 2 receptor (MC2R) activity in vitro (IC50 = 66 nM). GPS1573 antagonizes MC4R with IC50 of 950 nM, therefore showing selectivity for MC2R. The binding of ACTH to MC2R regulates steroidogenesis leading to metabolic diseases such as Cushing disease in patients with pituitary dysfunctions. | price> |
| R-M-1341 | GP38 HIV Peptide | GP38 peptide corresponds to aa 578-603 of HIV-2 gp160 envelope glycoprotein. GP38 includes the 17-amino acid long immunosuppressive region present in many retroviral envelope proteins. Peptides derived from this sequence inhibit immune function. GP38 antibodies are found in plasma of HIV-infected patient. | price> |
| R-M-1346 | GHRP-6 Peptide, Cas:87616-84-0 | The growth hormone-releasing peptide-6 (GHRP-6) is one of several synthetic met-enkephalin analogs that include unnatural D-amino acids. They were developed for their growth hormone (GH) releasing activity, then called GH secretatogues. They lack opioid activity but are potent stimulators of GH release. These secretatogues are distinct from the growth hormone releasing hormone (GHRH or GHRF) in that they share no sequence relation and derive their function through action at a completely different receptor, the ghrelin receptor. | price> |
| R-M-1348 | GHRP-4 Peptide,CAS:104180-25-8 | The growth hormone-releasing peptide-4 (GHRP-4) is one of several synthetic met-enkephalin analogs that include unnatural D-amino acids. They were developed for their growth hormone (GH) releasing activity, then called GH secretatogues. They lack opioid activity but are potent stimulators of GH release. These secretatogues are distinct from the growth hormone releasing hormone (GHRH or GHRF) in that they share no sequence relation and derive their function through action at a completely different receptor, the ghrelin receptor. | price> |
| R-M-1350 | GHRF [1-44] Peptide,Cas:83930-13-6 | The growth hormone-releasing factor (GHRF) is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone. GHRH is available under the names Groliberin (Pharmacia), Somatrel (Ferring) and Geref (acetylated aa 1-29, Serono) for the treatment of growth hormone deficiency. | price> |
| R-M-1351 | GHRF Peptide (Rat),Cas:86472-71-1 | The growth hormone-releasing factor (GHRF) is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone. | price> |
| R-M-1352 | GHRF Peptide (Ovine) | The growth hormone-releasing factor (GHRF) is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone. | price> |
| R-M-1353 | GHRF Peptide (Mouse) | The growth hormone-releasing factor (GHRF) is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone. | price> |
| R-M-1354 | GHRF Peptide (Bovine),CAS: 88894-91-1 | The growth hormone-releasing factor (GHRF) is released by the hypothalamus and acts on the adenohypophyse to stimulate the secretion of growth hormone. | price> |
| R-M-1356 | GRP Peptide,Cas:93755-85-2 | The gastrin-releasing peptide (GRP) stimulates the release of gastrin and gastrointestinal hormones. | price> |

Items-$0.00

Email:
Tel.:
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


